Mayo Clinic November 13, 2024
John Halamka

It’s not an easy question to answer, but with a well thought out roadmap, it’s doable.

By John Halamka, M.D., President, Mayo Clinic Platform and Paul Cerrato, MA, senior research analyst and communications specialist, Mayo Clinic Platform, and Sonya Makhni, MD, MS, MBA, Medical Director, Mayo Clinic Platform.

By July 30, 2023, the US Food and Drug Administration had cleared almost 700 AI-enabled medical algorithms. Within a year, that number had grown to 950, and that does not include the many algorithms that do not require FDA clearance or approval. Unfortunately, the evidence strongly suggests that many of these digital tools, both approved and not, have a credibility problem because they lack transparency, measures of reliability, and demonstrated consistency.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Health System / Hospital, Provider, Technology
The Future of AI in Hospice Care
AI Curation In Tomorrow’s World Will Be Different
Medeloop Raises $15.5M for AI-Driven Medical Research Platform
NVentures Invests in Genesis Therapeutics’ AI Platform for Drug Development
Opinion: How I addressed racial bias in my company’s AI algorithm

Share This Article